Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-risk Myelodysplastic Syndromes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00110266
What this trial is testing

Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients

Who this might be right for
Myelodysplastic SyndromeIron Overload
Novartis Pharmaceuticals 176
Testing effectiveness (Phase 2)Looking for participantsNCT05184842
What this trial is testing

Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia
Montefiore Medical Center 91
Large-scale testing (Phase 3)Active Not RecruitingNCT05469737
What this trial is testing

Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic Syndromes
Bristol-Myers Squibb 230
Testing effectiveness (Phase 2)UnknownNCT00443339
What this trial is testing

Darbepoetin Alpha in Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndromes
Groupe Francophone des Myelodysplasies 99
Large-scale testing (Phase 3)Study completedNCT00003805
What this trial is testing

Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count

Who this might be right for
Bone Marrow SuppressionFever, Sweats, and Hot FlashesInfection+6 more
European Organisation for Research and Treatment of Cancer - EORTC 859
Testing effectiveness (Phase 2)Study completedNCT01868477
What this trial is testing

Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.

Who this might be right for
Low and Int 1-risk Myelodysplastic Syndrome
Novartis Pharmaceuticals 28
Early research (Phase 1)Active Not RecruitingNCT03843528
What this trial is testing

Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesMixed Phenotype Acute Leukemia+1 more
Johns Hopkins All Children's Hospital 15
Large-scale testing (Phase 3)Study completedNCT03303066
What this trial is testing

Efficacy and Safety of FG-4592 for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
AnemiaMyelodysplastic Syndrome
Kyntra Bio 43